Programma

The Dutch DRUP study

Emile Voest, AvL, Amsterdam

Targeting KRAS: new hopes?

Egbert Smit, AvL, Amsterdam

Hopes and concerns in IO treatment

Solange Peters, CHUV, Lausanne

Anti-angiogenesis: any future in 2020?

Francis Shepherd, Princess Margaret Cancer Centre, Toronto

NVALT 19

Sjaak Burgers, AvL, Amsterdam

How to treat the individual patient with target agents

Tony Mok (t.b.c.), Chinese University of Hong Kong, Hong Kong

The cigarette: Addictive by Design

Jeffrey Wigand, Smoke-Free Kids Inc, Mount Pleasant (MI)

Proton therapy in Lung Cancer

Hans Langendijk (t.b.c.), UMC Groningen

Oligometastatic disease introduction

Lizza Hendriks, Maastricht UMC+

Pro SBRT

M. Guckenberg, University of Würzburg, Würzburg

Pro surgery

John Edwards, Sheffield Teaching Hospital

Voting and discussion

IAS studieprijs